AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Venforis 37.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Curis Lifecare

Salt Composition

Venlafaxine (37.5mg)

Overview Venforis 37.5mg Tablet ER

Elanzia XR 37.5mg tablets treat depressive and anxiety disorders by modifying brain chemistry responsible for anxiety symptoms. These include agitation, hyperactivity, poor concentration, lethargy, perspiration, tachycardia, and racing thoughts. Take Elanzia XR 37.5mg with food at the same time daily for consistent blood levels. Missed doses should be taken promptly; complete the prescribed course, even if feeling improved. Abrupt cessation may worsen symptoms. Common side effects – nausea, vomiting, sleep disturbances, reduced appetite, heightened anxiety, constipation, increased sweating, and sexual difficulties – are typically transient. Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until the effects are known. Persistent or bothersome side effects warrant medical attention. Prior to commencing Elanzia XR 37.5mg, disclose any kidney, heart, or liver issues, or history of seizures. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation to your physician immediately.

Uses of Venforis 37.5mg Tablet ER

Mood disorders encompassing depressive and anxious symptoms

Major Benefits of Venforis 37.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 37.5mg extended-release Venforis tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.

Common Side effects of Venforis 37.5mg Tablet ER:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Venforis 37.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 37.5mg extended-release Venforis tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

How Venforis 37.5mg Tablet ER works:

Venforis 37.5mg Extended-Release tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Venforis 37.5mg Extended-Release Tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Venforis 37.5mg tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Venforis 37.5mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a risk to infants. Close observation of newborns for sufficient weight gain and absence of excessive drowsiness is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Venforis 37.5mg Extended-Release Tablets due to potential side effects. These side effects can include dizziness, confusion, and visual disturbances like blurred vision, all of which could negatively impact driving skills.

KidneyKidneyCAUTION

Patients with kidney impairment should use Venforis 37.5mg Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Venforis 37.5mg Extended-Release tablets. Dosage modification may be necessary; physician consultation is advised.

What if you forget to take Venforis 37.5mg Tablet ER :

Should you forget a Venforis 37.5mg Extended-Release Tablet, take it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your normal dosing regimen. Never take a double dose.

Facts to Know About Venforis 37.5mg Tablet ER

LabelValue
Chemical Type Anisole-based Compound
Developing Habits No.
Treatment Category Neuroscience (CNS)
Action Class SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Venforis 37.5mg Tablet ER

Sedation is a possible side effect of Venforis 37.5mg Tablet ER. Inform your doctor about any other sleep aids you're using before starting this medication.
Yes. Venforis 37.5mg Extended-Release tablets are classified as psychotropic medication, a category encompassing drugs that influence mental processes, emotions, and behavior.
Venforis 37.5mg Extended-Release Tablets are not narcotics. Narcotics are opioid-derived drugs, such as heroin and morphine, that induce sleep.
Venforis 37.5mg tablets, whether ER or XR, are identical extended-release formulations. This slow release maintains consistent medication levels, reducing the frequency of dosing.
Mirtazapine and Venforis 37.5mg ER tablets together pose a serious risk of serotonin syndrome. This potentially life-threatening condition can manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Combining citalopram and Venforis 37.5mg ER tablets, which both raise serotonin levels, risks causing serotonin syndrome. This potentially fatal condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, unstable blood pressure, high fever, and coma. Avoid concurrent use; alternative medications should be considered.
Venforis 37.5mg Tablet ER is removed from the brain by P-glycoprotein, but studies indicate that both the drug and its metabolite can inhibit this transporter.
Venforis 37.5mg Extended-Release tablets are absorbed into the bloodstream following hepatic metabolism.
Venforis 37.5mg Extended-Release Tablets treat generalized depression. Always consult your physician before use.
Some individuals taking Venforis 37.5mg Extended-Release tablets experience sustained blood pressure increases. Regular blood pressure monitoring is recommended for these patients, with potential dose reduction or treatment discontinuation considered as necessary.
Yes, Venforis 37.5mg Extended-Release tablets can cause constipation. Increase fiber intake and fluid consumption. Laxatives may be helpful. Your doctor can advise on prevention and management. Consult your doctor if constipation persists or worsens.
Weight loss is a reported side effect of Venforis 37.5mg Tablet ER, observed in studies at varying doses over several weeks. Consult your physician if this concerns you.
Venforis 37.5mg Extended-Release Tablets are not habit-forming.
Consult your doctor before substituting tablets for capsules. Altering your medication without professional guidance is risky, as different formulations affect drug release and may result in treatment inefficacy, side effects, or even treatment failure.
Yes, gabapentin can be combined with Venforis 37.5mg Tablet ER, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Caution is advised.
Venforis 37.5mg Tablet ER contains desvenlafaxine, its active ingredient.
Venforis 37.5mg Extended-Release Tablets are not FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication for fibromyalgia or any condition.
While not FDA-approved for nerve pain, Venforis 37.5mg Extended-Release Tablets have shown efficacy in some research studies and are used off-label for this purpose.
Venforis 37.5mg Extended-Release tablets affect brain neurotransmitters, reducing appetite in a dose-dependent manner.
Should you experience side effects such as reduced libido or erectile dysfunction, consult your doctor who may prescribe an alternative medication. Do not discontinue Venforis 37.5mg Tablet ER without medical supervision, as this may worsen side effects.
Venforis 37.5mg Tablet ER
35
MRP 40
12% off